Quantcast

Latest InnerCool Therapies Inc. Stories

2010-01-04 16:57:00

SAN DIEGO, Jan.

2009-07-24 08:00:00

SAN DIEGO, July 24 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) ("Cardium") today announced that it has completed the asset sale of Cardium's InnerCool Therapies business ("InnerCool") to Royal Philips Electronics (NYSE: PHG, AEX: PHI).

2009-07-15 07:05:00

AMSTERDAM and SAN DIEGO, July 15 /PRNewswire-FirstCall/ -- Royal Philips (AEX: PHI, NYSE: PHG) announced today that it has reached an agreement to acquire the assets of InnerCool Therapies Inc., a pioneer in the field of therapeutic hypothermia, which involves the management of a patient's body temperature.

2009-07-15 07:00:00

SAN DIEGO, July 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) ("Cardium") today announced that it has entered into a definitive Asset Purchase Agreement for the acquisition of Cardium's InnerCool Therapies business ("InnerCool") by Royal Philips Electronics (NYSE: PHG, AEX: PHI).

2009-06-17 08:00:00

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced it is scheduled to join the broad-market Russell 3000 Index when Russell Investments reconstitutes its comprehensive set of U.S.

2009-05-28 08:00:00

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) today announced a presentation entitled "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers" at the Late Stage Industry Clinical Trials Symposium at the American Society of Gene Therapy (ASGT) Annual meeting in San Diego, California, on May 27, 2009.

2009-05-12 08:15:00

SAN DIEGO, May 12 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that the Company will hold a conference call and webcast to discuss recent developments and future plans for its Excellarate(TM) clinical development program.

2009-05-11 16:33:00

SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported its financial results for its first quarter ended March 31, 2009, and on recent developments and future outlook. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO) Cardium made significant progress in the first quarter 2009 as the Company continued to focus its efforts on the InnerCool Therapies and Tissue Repair Company subsidiaries, both of which we believe are advancing toward...

2009-05-07 08:00:00

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) today announced significant new formulation enhancements for its Excellarate(TM) product candidate that are designed to simplify and broaden the use of Excellarate for diabetic ulcers, and also expand the potential applicability into a number of additional wound healing market opportunities, including pressure and venous stasis ulcers, as well as major surgical and...


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.